NCT00320567View on ClinicalTrials.gov

The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 2004

Conditions
Osteoporosis
Interventions
DRUG

norgestimate/ethinyl estradiol

All Listed Sponsors
lead

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

NCT00320567 - The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa | Biotech Hunter | Biotech Hunter